NovaBay Pharmaceuticals Inc (NBY)
0.0821
0.00 (0.00%)
USD |
NYAM |
Apr 17, 16:00
0.0812
0.00 (0.00%)
After-Hours: 20:00
NovaBay Pharmaceuticals Cash from Financing (TTM): 1.91M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 1.91M |
September 30, 2023 | 4.971M |
June 30, 2023 | 7.251M |
March 31, 2023 | 4.738M |
December 31, 2022 | 4.633M |
September 30, 2022 | 16.39M |
June 30, 2022 | 14.91M |
March 31, 2022 | 16.68M |
December 31, 2021 | 16.79M |
September 30, 2021 | 1.999M |
June 30, 2021 | 7.793M |
March 31, 2021 | 10.13M |
December 31, 2020 | 9.762M |
September 30, 2020 | 9.103M |
June 30, 2020 | 9.942M |
March 31, 2020 | 8.354M |
December 31, 2019 | 11.70M |
September 30, 2019 | 12.36M |
June 30, 2019 | 5.504M |
March 31, 2019 | 2.978M |
December 31, 2018 | 5.597M |
September 30, 2018 | 5.662M |
June 30, 2018 | 5.808M |
March 31, 2018 | 5.852M |
December 31, 2017 | 0.201M |
Date | Value |
---|---|
September 30, 2017 | 0.994M |
June 30, 2017 | 10.67M |
March 31, 2017 | 15.38M |
December 31, 2016 | 19.42M |
September 30, 2016 | 22.13M |
June 30, 2016 | 12.64M |
March 31, 2016 | 14.94M |
December 31, 2015 | 15.60M |
September 30, 2015 | 12.45M |
June 30, 2015 | 12.48M |
March 31, 2015 | 5.483M |
December 31, 2014 | 7.386M |
September 30, 2014 | 13.98M |
June 30, 2014 | 15.46M |
March 31, 2014 | 15.85M |
December 31, 2013 | 9.327M |
September 30, 2013 | 10.50M |
June 30, 2013 | 9.977M |
March 31, 2013 | 9.537M |
December 31, 2012 | 9.472M |
September 30, 2012 | 1.408M |
June 30, 2012 | 4.737M |
March 31, 2012 | 4.73M |
December 31, 2011 | 4.701M |
September 30, 2011 | 4.533M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
1.91M
Minimum
Dec 2023
16.79M
Maximum
Dec 2021
9.206M
Average
9.103M
Median
Sep 2020
Cash from Financing (TTM) Benchmarks
Eyenovia Inc | 19.79M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Ampio Pharmaceuticals Inc | 0.00 |